{
    "id": 25060,
    "fullName": "FGFR2 - FAM76A",
    "impact": "fusion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FGFR2-FAM76A results from the fusion of FGFR2 and FAM76A, which leads to increased proliferation and transformation in cell culture (PMID: 24563622) and therefore, is predicted to result in a gain of protein function. FGFR2-FAM76A has been identified in ovarian cancer (PMID: 24563622).",
            "references": [
                {
                    "id": 6413,
                    "pubMedId": 24563622,
                    "title": "Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24563622"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2263,
        "geneSymbol": "FGFR2",
        "terms": [
            "FGFR2",
            "BBDS",
            "BEK",
            "BFR-1",
            "CD332",
            "CEK3",
            "CFD1",
            "ECT1",
            "JWS",
            "K-SAM",
            "KGFR",
            "TK14",
            "TK25"
        ]
    },
    "variant": "FGFR2 - FAM76A",
    "createDate": "08/02/2016",
    "updateDate": "02/24/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 199870,
                "geneSymbol": "FAM76A",
                "terms": [
                    "FAM76A"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 7543,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclincal study, BGJ398 demonstrated enhanced inhibition of the survival in patient-derived ovarian cancer cells harboring FGFR2 - FAM76A in culture (PMID: 24563622).",
            "molecularProfile": {
                "id": 25826,
                "profileName": "FGFR2 - FAM76A"
            },
            "therapy": {
                "id": 674,
                "therapyName": "BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6413,
                    "pubMedId": 24563622,
                    "title": "Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24563622"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25826,
            "profileName": "FGFR2 - FAM76A",
            "profileTreatmentApproaches": [
                {
                    "id": 19589,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR2 - FAM76A"
                },
                {
                    "id": 19588,
                    "name": "FGFR2 Inhibitor",
                    "profileName": "FGFR2 - FAM76A"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}